AbSci

AbSci

AbSci

A company that has developed an E. coli expression system for optimized and scalable antibody and protein production.
Founded
2011
Raised
$17.1M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$5,100,000
Venture capital (Series A) - 2016
Phoenix Venture Partners
Team Size
1–10
Employees
FinSMEs

AbSci Raises $15.4M in Series D Funding

$12,000,000 Venture capital (Series C)
GeekWire , PE HUB , FinSMEs

Biomanufacturing company AbSci raises $12M to scale synthetic biology platform

Funding Science
$5,100,000 Venture capital (Series A)
Columbian.com

Biotech firm secures $5.1M to further work in proteins